adverse side effects

FOSAMAX UPDATE: New Research Confirms Long-Term Use of Osteoporosis Drugs Are Linked to Femoral Fractures

A new study titled “Bisphosphonate Use and Atypical Fractures of the Femoral Shaft” published in the May 2011 issue of the New England Journal of Medicines further strengthens the claim that bisphosphonates, like Fosamax, may increase the risk of atypical thigh bone breaks. This is the 4th study from the publication which favorably promotes the mounting litigation against the drug’s manufacturer Merck for allegedly producing a defective and harmful drug, ultimately providing Parilman Fosamax Femur Fracture lawyers with more fuel to obtain justice for patients harmed by defective drugs.Read More »FOSAMAX UPDATE: New Research Confirms Long-Term Use of Osteoporosis Drugs Are Linked to Femoral Fractures